What are Tandem Diabetes Care's total assets?

Tandem Diabetes Care (TNDM) holds $1.2B in total assets, up 25.1% year over year.

How much debt does Tandem Diabetes Care have?

Tandem Diabetes Care carries $734.7M in total debt against $132.4M of shareholders' equity, a debt-to-equity ratio of 5.55.

How much cash does Tandem Diabetes Care have?

Tandem Diabetes Care holds $179.3M in cash and equivalents.

Can Tandem Diabetes Care cover its short-term obligations?

Its current ratio is 3.58 — current assets exceed current liabilities.

Where does Tandem Diabetes Care's balance sheet data come from?

Every line is extracted from Tandem Diabetes Care's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Tandem Diabetes Care TNDM Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$90.63M+30.9%	$69.23M+17.6%	$58.87M-65.9%	$172.52M+142%
Short-term investments	$202.03M-45.3%	$369.1M-9.8%	$409.04M-8.0%	$444.38M-19.6%
Accounts receivable, net	$165.49M+44.4%	$114.59M+8.6%	$105.56M-8.0%	$114.72M+3.6%
Inventories	$128.77M-13.9%	$149.61M-5.3%	$157.94M+42.1%	$111.12M+62.1%
Raw materials	$31.77M-2.6%	$32.6M-23.8%	$42.78M+9.1%	$39.21M+45.7%
Work in process	$23.81M-29.0%	$33.52M-23.9%	$44.03M+137%	$18.57M+11.8%
Finished goods	$73.19M-12.3%	$83.49M+17.4%	$71.13M+33.4%	$53.34M+113%
Prepaid expenses and other current assets	$31.22M+42.1%	$21.97M+32.4%	$16.59M+129%	$7.24M-14.1%
Trading assets	——	——	——	——
Total current assets	$618.14M-14.7%	$724.49M-3.1%	$747.99M-12.0%	$849.98M+4.7%
Property and equipment, net	$83.58M+6.9%	$78.15M+2.1%	$76.54M+11.7%	$68.55M+36.1%
Operating lease right-of-use assets	5.8%-8,530,599,994%	8,530,600,000%-248,500,000%	8,779,100,000%-2,283,500,000%	11,062,600,000%+8,312,300,000%
Other non-current assets	$22.87M+343%	$5.17M-87.2%	$40.34M+70.7%	$23.63M+50.2%
Equity method investments	$60.35M-19.0%	$74.55M—	$0—	——
Total assets	$881.11M-8.9%	$967.66M+1.6%	$952.66M-9.5%	$1.05B+16.3%
Accounts payable	$47.07M+5.2%	$44.73M-9.8%	$49.59M-11.0%	$55.73M+98.8%
Accrued expenses	$70.41M+9.8%	$64.13M+47.7%	$43.43M+12.3%	$38.68M-25.0%
Deferred revenue	$9.53M-19.5%	$11.83M-73.1%	$43.99M+134%	$18.84M+85.0%
Operating lease liabilities, current	$19.47M+6.9%	$18.21M+6.7%	$17.06M+30.0%	$13.12M+41.4%
Contract liabilities	$8.47M-18.9%	$10.46M-21.6%	$13.33M-21.0%	$16.87M-0.4%
Total current liabilities	$242.72M-1.8%	$247.05M+26.5%	$195.26M+18.1%	$165.29M+25.4%
Long-term debt	$310.04M+0.6%	$308.27M+8.2%	$285.04M—	——
Operating lease liabilities, non-current	$114.97M+8.0%	$106.42M-6.3%	$113.57M-8.1%	$123.52M+416%
Operating Lease Liabilities (Total)	$134.44M+7.9%	$124.63M-4.6%	$130.63M-4.4%	$136.65M+312%
Other non-current liabilities	$49.74M+53.7%	$32.37M+1.7%	$31.83M+33.1%	$23.92M+34.1%
Total liabilities	$725.94M+3.0%	$704.56M+10.3%	$639.03M+4.3%	$612.84M+29.8%
Common stock	200M+302,930%	66K0.0%	66K+1.5%	65K+1.6%
Additional paid-in capital	$1.4B+6.8%	$1.31B+3.9%	$1.26B+8.0%	$1.17B+9.6%
Retained earnings	-$1.25B-19.5%	-$1.05B-10.1%	-$951.8M-30.5%	-$729.19M-14.9%
Accumulated other comprehensive income (loss)	$5.59M+387%	-$1.95M-242%	$1.37M+175%	-$1.82M-195%
Total stockholders' equity	$155.17M-41.0%	$263.1M-16.1%	$313.63M-28.7%	$439.95M+1.6%
Total liabilities and stockholders' equity	$881.11M-8.9%	$967.66M+1.6%	$952.66M-9.5%	$1.05B+16.3%
Commitments and contingencies	$0—	$0—	$0—	$0—
Available-for-Sale Debt Securities - Amortized Cost	$201.08M-45.5%	$368.66M-9.7%	$408.3M-8.7%	$447.24M-19.2%
Available-for-Sale Debt Securities - Fair Value by Maturity	——	——	——	——
Available-for-Sale Debt Securities - Single Maturity Date	——	——	——	——
Allowance for Doubtful Accounts	$8.39M+15.7%	$7.25M+48.0%	$4.9M+13.2%	$4.33M+1.8%
Allowance for Doubtful Accounts Receivable (Current)	$8.39M+15.7%	$7.25M+48.0%	$4.9M+13.2%	$4.33M+1.8%
Cash, Cash Equivalents, and Marketable Securities	$202.03M-45.3%	$369.1M-9.8%	$409.04M-8.0%	$444.38M-19.6%
Deferred Tax Assets and Other Non-Current Assets	$22.87M+343%	$5.17M-87.2%	$40.34M+70.7%	$23.63M+50.2%
Investments - Amortized Cost Basis	$201.08M-45.5%	$368.66M-9.7%	$408.3M-8.7%	$447.24M-19.2%
Net Investment in Lease	$96.17M+12.7%	$85.31M-2.8%	$87.79M-20.6%	$110.63M+302%
Operating lease right-of-use assets	$96.17M+12.7%	$85.31M-2.8%	$87.79M-20.6%	$110.63M+302%
Other non-current assets	$22.87M+343%	$5.17M-87.2%	$40.34M+70.7%	$23.63M+50.2%
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$202.03M-45.3%	$369.1M-9.8%	$409.04M-8.0%	$444.38M-19.6%
Operating Lease Right-of-Use Assets in Other Assets	$96.17M+12.7%	$85.31M-2.8%	$87.79M-20.6%	$110.63M+302%
Software and Technology Licenses, Net	$22.87M+343%	$5.17M-87.2%	$40.34M+70.7%	$23.63M+50.2%
Accrued Manufacturing Costs	$70.41M+9.8%	$64.13M+47.7%	$43.43M+12.3%	$38.68M-25.0%
Accrued Progress Collections and Price Adjustments	$8.47M-18.9%	$10.46M-21.6%	$13.33M-21.0%	$16.87M-0.4%
Other Commercial Liabilities	$21.01M+15.6%	$18.17M+42.8%	$12.73M+32.6%	$9.6M+1.9%
Commercial Paper Outstanding	——	——	——	——
Accrued Liabilities, Current	$21.01M+15.6%	$18.17M+42.8%	$12.73M+32.6%	$9.6M+1.9%
Compensation and benefits	$70.41M+9.8%	$64.13M+47.7%	$43.43M+12.3%	$38.68M-25.0%
Other accrued liabilities	$75.24M+52.6%	$49.31M+73.3%	$28.46M-2.9%	$29.33M+25.4%
Current portion of accrued product warranty	$33.28M+7.2%	$31.05M+71.2%	$18.14M+4.9%	$17.28M+32.2%
Operating Lease Liability Payments - 2024 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	——	——	——
Lease Liability Payments - Due Year Two	——	——	——	——
Lease Liability Payments - Due Year Three	——	——	——	——
Lease Liability Payments - Due Year Four	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——
Operating Lease Liability Payments Due	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	——	——	——
Standard Product Warranty Accrual	$55.32M+7.6%	$51.41M+38.3%	$37.17M+1.7%	$36.54M+20.2%
Contract Liabilities, Non-Current	$8.47M-18.9%	$10.46M-21.6%	$13.33M-21.0%	$16.87M-0.4%
Convertible Debt (Non-Current)	$310.04M+0.6%	$308.27M+8.2%	$285.04M+0.6%	$283.23M+0.6%
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	——	——	——	——
Operating Lease Liability Payments - 2026 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2027 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	——	——	——
Operating Lease Liability Payments - 2029 (Lessee)	——	——	——	——
Lease Liability Payments - Due After Year Five	——	——	——	——
Operating Lease Liability Payments - Thereafter (Lessee)	——	——	——	——
Deferred revenue, net of current portion	$8.47M-18.9%	$10.46M-21.6%	$13.33M-21.0%	$16.87M-0.4%
Total debt	$444.48M-13.6%	$514.24M+23.7%	$415.67M+204%	$136.65M+312%
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	68.3M+3.1%	66.3M+1.1%	65.6M+1.6%	64.5M+1.1%
Additional paid-in capital	$1.4B+6.8%	$1.31B+3.9%	$1.26B+8.0%	$1.17B+9.6%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$68K+3.0%	$66K0.0%	$66K+1.5%	$65K+1.6%
Shares Reserved for Future Issuance Under Stock Plans	——	——	——	——
Unrealized Gains on Investments	$963K+26.9%	$759K-26.0%	$1.03M+3,317%	$30K+100%
Unrealized Losses on Investments (Before Tax)	$10K-96.9%	$321K+16.3%	$276K-90.4%	$2.89M+352%
Cumulative Cost Basis	$201.08M-45.5%	$368.66M-9.7%	$408.3M-8.7%	$447.24M-19.2%
Accounts Receivable, after Allowance for Credit Loss	$165.49M+44.4%	$114.59M+8.6%	$105.56M-8.0%	$114.72M+3.6%
Accounts Receivable, Allowance for Credit Loss	$8.39M+15.7%	$7.25M+48.0%	$4.9M+13.2%	$4.33M+1.8%
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$10K-96.9%	$321K+16.3%	$276K-90.4%	$2.89M+352%
Gross Unrealized Gains	$963K+26.9%	$759K-26.0%	$1.03M+3,317%	$30K+100%
Total	$201.08M-45.5%	$368.66M-9.7%	$408.3M-8.7%	$447.24M-19.2%
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One	——	——	——	——
Available for sale investments	$202.03M-45.3%	$369.1M-9.8%	$409.04M-8.0%	$444.38M-19.6%
Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right	——	——	——	——
Common stock, capital shares reserved for future issuance	——	——	——	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$200M0.0%	$200M0.0%	$200M0.0%	$200M0.0%
Common stock, shares issued (in shares)	$68.29M+3.1%	$66.26M+1.1%	$65.55M+1.6%	$64.51M+1.1%
Common Stock, Shares, Outstanding	$68.29M+3.1%	$66.26M+1.1%	$65.55M+1.6%	$64.51M+1.1%
Convertible debentures	$310.04M+0.6%	$308.27M+8.2%	$285.04M+0.6%	$283.23M+0.6%
One to Two Years	——	——	——	——
Two to Three Years	——	——	——	——
Equity method investments (Note 11)	$60.35M-19.0%	$74.55M—	$0—	——
Raw materials	$31.77M-2.6%	$32.6M-23.8%	$42.78M+9.1%	$39.21M+45.7%
Lessee Operating Lease Liability Payments Due	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	——	——
Letters of Credit Outstanding, Amount	——	——	——	——
Number of geographical markets	——	——	——	——
Operating Lease Weighted Average Discount Rate Percent	$0.06+9.4%	$0.05-1.9%	$0.05+1.9%	$0.05-5.4%
Standard and Extended Product Warranty Accrual	$55.32M+7.6%	$51.41M+38.3%	$37.17M+1.7%	$36.54M+20.2%
Long-term portion of accrued product warranty	$22.04M+8.3%	$20.36M+6.9%	$19.04M-1.1%	$19.26M+11.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Tandem Diabetes Care.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Tandem Diabetes Care's total assets?: Tandem Diabetes Care (TNDM) holds $1.2B in total assets, up 25.1% year over year.
How much debt does Tandem Diabetes Care have?: Tandem Diabetes Care carries $734.7M in total debt against $132.4M of shareholders' equity, a debt-to-equity ratio of 5.55.
How much cash does Tandem Diabetes Care have?: Tandem Diabetes Care holds $179.3M in cash and equivalents.
Can Tandem Diabetes Care cover its short-term obligations?: Its current ratio is 3.58 — current assets exceed current liabilities.
Where does Tandem Diabetes Care's balance sheet data come from?: Every line is extracted from Tandem Diabetes Care's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.